首页 > 最新文献

Archives of Academic Emergency Medicine最新文献

英文 中文
Effects of Pre-Hospital Dexamethasone Administration on Outcomes of Patients with COPD and Asthma Exacerbation; a Cross-Sectional Study. 院前给药地塞米松对COPD合并哮喘加重患者预后的影响横断面研究
IF 5.4 Q1 EMERGENCY MEDICINE Pub Date : 2023-01-01 DOI: 10.22037/aaem.v11i1.2037
Thongpitak Huabbangyang, Agasak Silakoon, Chunlanee Sangketchon, Jareeda Sukhuntee, Jukkit Kumkong, Tanut Srithanayuchet, Parinya Chamnanpol, Theeraphat Meechai

Introduction: Chronic obstructive pulmonary disease (COPD) and asthma exacerbation are two common emergency situations. This study aimed to investigate the impact of pre-hospital dexamethasone initiation on treatment outcomes of these patients.

Methods: In this retrospective cross-sectional and comparative study, data from the emergency medical service (EMS) care report of patients with a final diagnosis of asthma or COPD, coded with Thailand's emergency medical triage protocol, collected between January 1, 2021, and October 31, 2022, were used. Data on baseline characteristics, emergency department length of stay (ED-LOS), and hospital admission rates were collected from electronic medical records and compared between cases with and without pre-hospital dexamethasone administration by EMS.

Results: 200 patients with COPD (n = 93) and asthma (n = 107) exacerbation were enrolled. The dexamethasone-treated group had a lower but statistically non-significant hospital admission rate (71.0% versus 81.0%, absolute difference: -10%, 95% confidence interval (CI): -21.76, 1.76; p = 0.100). In patients with asthma, the dexamethasone-treated had lower median ED-LOS time (235 (IQR: 165.5-349.5) versus 322 (IQR: 238-404) minutes; p = 0.003). Dexamethasone-treated asthma patients had lower but statistically non-significant hospital admission rates (60.4% versus 78.0%, absolute difference: -17.55%, 95% CI: -34.96, -0.14; p = 0.510). In COPD patients the dexamethasone-treated and untreated groups had non-significantly lower hospital admission rates (80.8% versus 85.40%, absolute difference: -4.60%, 95% CI: -19.82, 10.63; p = 0.561) and non-significantly lower ED-LOS (232 (IQR: 150 - 346) versus 296 (IQR: 212 - 330) minutes, absolute difference: -59 (-130.81, 12.81); p = 0.106).

Conclusion: The dexamethasone administration by EMS in pre-hospital setting for management of asthma and COPD patients is beneficial in reducing the ED-LOS and need for hospital admission but its effects are not statistically significant, except regarding the ED-LOS of asthma exacerbation cases.

慢性阻塞性肺疾病(COPD)和哮喘加重是两种常见的紧急情况。本研究旨在探讨院前地塞米松启动对这些患者治疗结果的影响。方法:在这项回顾性横断面比较研究中,使用了2021年1月1日至2022年10月31日期间收集的急诊医疗服务(EMS)护理报告数据,这些数据由泰国紧急医疗分诊方案编码,最终诊断为哮喘或COPD。从电子病历中收集基线特征、急诊科住院时间(ED-LOS)和住院率的数据,并比较EMS给予和未给予院前地塞米松的病例。结果:纳入200例COPD加重患者(n = 93)和哮喘加重患者(n = 107)。地塞米松治疗组住院率较低,但无统计学意义(71.0% vs 81.0%,绝对差异为-10%,95%可信区间(CI): -21.76, 1.76;P = 0.100)。在哮喘患者中,地塞米松治疗组ED-LOS时间中位数较低(235 (IQR: 165.5-349.5) vs 322 (IQR: 238-404)分钟;P = 0.003)。地塞米松治疗的哮喘患者住院率较低,但无统计学意义(60.4% vs 78.0%,绝对差异:-17.55%,95% CI: -34.96, -0.14;P = 0.510)。在慢性阻塞性肺病患者中,地塞米松治疗组和未治疗组的住院率无显著降低(80.8%对85.40%,绝对差异:-4.60%,95% CI: -19.82, 10.63;p = 0.561), ED-LOS无显著降低(232 (IQR: 150 - 346) vs 296 (IQR: 212 - 330)分钟,绝对差异:-59 (-130.81,12.81);P = 0.106)。结论:院前EMS给药地塞米松治疗哮喘和COPD患者有利于降低ED-LOS和住院次数,但除哮喘加重患者ED-LOS外,其他效果均无统计学意义。
{"title":"Effects of Pre-Hospital Dexamethasone Administration on Outcomes of Patients with COPD and Asthma Exacerbation; a Cross-Sectional Study.","authors":"Thongpitak Huabbangyang,&nbsp;Agasak Silakoon,&nbsp;Chunlanee Sangketchon,&nbsp;Jareeda Sukhuntee,&nbsp;Jukkit Kumkong,&nbsp;Tanut Srithanayuchet,&nbsp;Parinya Chamnanpol,&nbsp;Theeraphat Meechai","doi":"10.22037/aaem.v11i1.2037","DOIUrl":"https://doi.org/10.22037/aaem.v11i1.2037","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic obstructive pulmonary disease (COPD) and asthma exacerbation are two common emergency situations. This study aimed to investigate the impact of pre-hospital dexamethasone initiation on treatment outcomes of these patients.</p><p><strong>Methods: </strong>In this retrospective cross-sectional and comparative study, data from the emergency medical service (EMS) care report of patients with a final diagnosis of asthma or COPD, coded with Thailand's emergency medical triage protocol, collected between January 1, 2021, and October 31, 2022, were used. Data on baseline characteristics, emergency department length of stay (ED-LOS), and hospital admission rates were collected from electronic medical records and compared between cases with and without pre-hospital dexamethasone administration by EMS.</p><p><strong>Results: </strong>200 patients with COPD (n = 93) and asthma (n = 107) exacerbation were enrolled. The dexamethasone-treated group had a lower but statistically non-significant hospital admission rate (71.0% versus 81.0%, absolute difference: -10%, 95% confidence interval (CI): -21.76, 1.76; p = 0.100). In patients with asthma, the dexamethasone-treated had lower median ED-LOS time (235 (IQR: 165.5-349.5) versus 322 (IQR: 238-404) minutes; p = 0.003). Dexamethasone-treated asthma patients had lower but statistically non-significant hospital admission rates (60.4% versus 78.0%, absolute difference: -17.55%, 95% CI: -34.96, -0.14; p = 0.510). In COPD patients the dexamethasone-treated and untreated groups had non-significantly lower hospital admission rates (80.8% versus 85.40%, absolute difference: -4.60%, 95% CI: -19.82, 10.63; p = 0.561) and non-significantly lower ED-LOS (232 (IQR: 150 - 346) versus 296 (IQR: 212 - 330) minutes, absolute difference: -59 (-130.81, 12.81); p = 0.106).</p><p><strong>Conclusion: </strong>The dexamethasone administration by EMS in pre-hospital setting for management of asthma and COPD patients is beneficial in reducing the ED-LOS and need for hospital admission but its effects are not statistically significant, except regarding the ED-LOS of asthma exacerbation cases.</p>","PeriodicalId":8146,"journal":{"name":"Archives of Academic Emergency Medicine","volume":"11 1","pages":"e56"},"PeriodicalIF":5.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6d/49/aaem-11-e56.PMC10475744.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10170197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Late Complications of COVID-19; An Umbrella Review on Current Systematic Reviews. COVID-19晚期并发症;当前系统评价的概括性综述。
IF 5.4 Q1 EMERGENCY MEDICINE Pub Date : 2023-01-01 DOI: 10.22037/aaem.v11i1.1907
SeyedAhmad SeyedAlinaghi, AmirBehzad Bagheri, Armin Razi, Paniz Mojdeganlou, Hengameh Mojdeganlou, Amir Masoud Afsahi, Arian Afzalian, Parinaz Paranjkhoo, Ramin Shahidi, Pegah Mirzapour, Zahra Pashaei, Mohammad Amin Habibi, Parmida Shahbazi, Sahar Nooralioghli Parikhani, Narjes Sadat Farizani Gohari, Yusuf Popoola, Esmaeil Mehraeen, Daniel Hackett

Introduction: Several clinical manifestations have been discovered for COVID-19 since the emergence of SARS-CoV-2, which can be classified into early, medium, and long-term complications. However, late complications can be present after recovery from acute COVID-19 illness. The present study aims to comprehensively review the available evidence of late complications related to COVID-19.

Method: A search was conducted, using keywords, through electronic databases, which included Scopus, Web of Science, PubMed, and Embase up to August 29, 2022. Study selection was performed according to a strict inclusion and exclusion criteria. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) checklist was followed, and studies were appraised using the National Institute of Health (NIH) quality assessment and risk of bias tool.

Results: In total, 50 studies were included, and nine distinct COVID-19 late complication categories were identified. A review of these studies revealed that neurologic and psychiatric (n=41), respiratory (n=27), musculoskeletal and rheumatologic (n=22), cardiovascular (n=9), and hepatic and gastrointestinal (n=6) complications were the most prevalent complications of long COVID-19.

Conclusion: Almost all human body systems are affected by late complications of COVID-19 with different severity and prevalence. Fatigue and some other neuropsychiatric symptoms are the most common late complications among long COVID-19 patients. Respiratory symptoms including dyspnea (during exercise), cough, and chest tightness were the next most prevalent long-term complications of COVID-19. Since these complications are persistent and late, being aware of the signs and symptoms is essential for the healthcare providers and patients.

自SARS-CoV-2出现以来,COVID-19出现了多种临床表现,可分为早期、中期和长期并发症。然而,急性COVID-19疾病恢复后可能出现晚期并发症。本研究旨在全面回顾与COVID-19相关的晚期并发症的现有证据。方法:使用关键词对截止到2022年8月29日的电子数据库Scopus、Web of Science、PubMed、Embase进行检索。根据严格的纳入和排除标准进行研究选择。遵循系统评价和荟萃分析首选报告项目(PRISMA)清单,并使用美国国立卫生研究院(NIH)质量评估和偏倚风险工具对研究进行评价。结果:共纳入50项研究,确定了9种不同的COVID-19晚期并发症类别。对这些研究的回顾显示,神经和精神(n=41)、呼吸(n=27)、肌肉骨骼和风湿病(n=22)、心血管(n=9)、肝脏和胃肠道(n=6)并发症是长期COVID-19最常见的并发症。结论:COVID-19晚期并发症对人体几乎所有系统都有影响,其严重程度和流行程度不同。疲劳和其他一些神经精神症状是长期COVID-19患者中最常见的晚期并发症。呼吸困难(运动时)、咳嗽和胸闷等呼吸系统症状是COVID-19最常见的长期并发症。由于这些并发症是持续性和迟发性的,因此了解体征和症状对医疗保健提供者和患者至关重要。
{"title":"Late Complications of COVID-19; An Umbrella Review on Current Systematic Reviews.","authors":"SeyedAhmad SeyedAlinaghi,&nbsp;AmirBehzad Bagheri,&nbsp;Armin Razi,&nbsp;Paniz Mojdeganlou,&nbsp;Hengameh Mojdeganlou,&nbsp;Amir Masoud Afsahi,&nbsp;Arian Afzalian,&nbsp;Parinaz Paranjkhoo,&nbsp;Ramin Shahidi,&nbsp;Pegah Mirzapour,&nbsp;Zahra Pashaei,&nbsp;Mohammad Amin Habibi,&nbsp;Parmida Shahbazi,&nbsp;Sahar Nooralioghli Parikhani,&nbsp;Narjes Sadat Farizani Gohari,&nbsp;Yusuf Popoola,&nbsp;Esmaeil Mehraeen,&nbsp;Daniel Hackett","doi":"10.22037/aaem.v11i1.1907","DOIUrl":"https://doi.org/10.22037/aaem.v11i1.1907","url":null,"abstract":"<p><strong>Introduction: </strong>Several clinical manifestations have been discovered for COVID-19 since the emergence of SARS-CoV-2, which can be classified into early, medium, and long-term complications. However, late complications can be present after recovery from acute COVID-19 illness. The present study aims to comprehensively review the available evidence of late complications related to COVID-19.</p><p><strong>Method: </strong>A search was conducted, using keywords, through electronic databases, which included Scopus, Web of Science, PubMed, and Embase up to August 29, 2022. Study selection was performed according to a strict inclusion and exclusion criteria. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) checklist was followed, and studies were appraised using the National Institute of Health (NIH) quality assessment and risk of bias tool.</p><p><strong>Results: </strong>In total, 50 studies were included, and nine distinct COVID-19 late complication categories were identified. A review of these studies revealed that neurologic and psychiatric (n=41), respiratory (n=27), musculoskeletal and rheumatologic (n=22), cardiovascular (n=9), and hepatic and gastrointestinal (n=6) complications were the most prevalent complications of long COVID-19.</p><p><strong>Conclusion: </strong>Almost all human body systems are affected by late complications of COVID-19 with different severity and prevalence. Fatigue and some other neuropsychiatric symptoms are the most common late complications among long COVID-19 patients. Respiratory symptoms including dyspnea (during exercise), cough, and chest tightness were the next most prevalent long-term complications of COVID-19. Since these complications are persistent and late, being aware of the signs and symptoms is essential for the healthcare providers and patients.</p>","PeriodicalId":8146,"journal":{"name":"Archives of Academic Emergency Medicine","volume":"11 1","pages":"e28"},"PeriodicalIF":5.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/17/2c/aaem-11-e28.PMC10197916.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9504738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Oral Care with Povidone-Iodine in the Prevention of Ventilator-Associated Pneumonia; a Systematic Review and Meta-Analysis. 聚维酮碘口腔护理对呼吸机相关性肺炎的预防作用系统评价和荟萃分析。
IF 5.4 Q1 EMERGENCY MEDICINE Pub Date : 2023-01-01 DOI: 10.22037/aaem.v11i1.1874
Amir Emami Zeydi, Arman Parvizi, Soudabeh Haddadi, Samad Karkhah, Seyed Javad Hosseini, Amirabbas Mollaei, Mahbobeh Firooz, Shahin Ramezani, Joseph Osuji, Pooyan Ghorbani Vajargah, Shadi Dehghanzadeh

Introduction: Ventilator-associated pneumonia (VAP) is one of the most common nosocomial infections affecting one-third of patients with mechanical ventilation. This study aimed to synthesize available evidence regarding the effect of treatment with povidone-iodine (PI) among adult patients admitted to intensive care units (ICUs) for the prevention of VAP.

Methods: An extensive search was conducted in online databases, including PubMed, Web of Science and Scopus, from the earliest records until January 1, 2023. STATA software v14 was used for statistical analysis. Publication bias was assessed via funnel plot, Begg's and Egger's tests. A P-value less than 0.1 was considered statistically significant for publication bias value.

Results: Four studies were included in the meta-analysis. Three studies showed rhat PI decreased VAP compared to the placebo group, but it was not statistically significant (RR: 0.61, 95%CI: 0.25 to 1.47, Z=1.10, P=0.27, I2:71.5%). One study compared the effect of PI with chlorhexidine on the rate of VAP, the difference between which was not statistically significant (RR: 1.50, 95%CI: 0.46 to 4.87, Z=0.67, P=0.50, I2:0). Two studies demonstrated that the use of PI intervention compared to placebo decreased the average length of stay in ICU; however, it was not statistically significant (WMD: -0.35, 95%CI:-3.90 to 3.20, Z=0.19, P=0.85, I2:0). Also, three studies showed that using PI had almost no effect on mortality rate compared to placebo (RR: 1.05, 95%CI: 0.66 to 1.53, Z=0.8, P=0.27, I2:29.0%).

Conclusion: More rigorously designed randomized clinical trials and further evidence are required to make a better decision/comparison about using PI as a suitable choice for preventing VAP among adult patients admitted to the ICU.

简介:呼吸机相关性肺炎(VAP)是最常见的医院感染之一,影响三分之一的机械通气患者。本研究旨在综合有关重症监护病房(icu)成年患者使用聚维酮碘(PI)治疗预防VAP的效果的现有证据。方法:广泛检索PubMed、Web of Science、Scopus等在线数据库,从最早记录到2023年1月1日。采用STATA软件v14进行统计分析。通过漏斗图、Begg’s和Egger’s检验评估发表偏倚。p值小于0.1认为发表偏倚值具有统计学意义。结果:meta分析纳入了4项研究。三项研究显示,与安慰剂组相比,rpi降低了VAP,但无统计学意义(RR: 0.61, 95%CI: 0.25 ~ 1.47, Z=1.10, P=0.27, I2:71.5%)。一项研究比较PI与氯己定对VAP率的影响,两组比较差异无统计学意义(RR: 1.50, 95%CI: 0.46 ~ 4.87, Z=0.67, P=0.50, I2:0)。两项研究表明,与安慰剂相比,使用PI干预可缩短ICU的平均住院时间;但差异无统计学意义(WMD: -0.35, 95%CI:-3.90 ~ 3.20, Z=0.19, P=0.85, I2:0)。此外,三项研究表明,与安慰剂相比,使用PI对死亡率几乎没有影响(RR: 1.05, 95%CI: 0.66至1.53,Z=0.8, P=0.27, i2:29 0%)。结论:需要更严格设计的随机临床试验和进一步的证据来更好地决定/比较在ICU成年患者中使用PI作为预防VAP的合适选择。
{"title":"Effect of Oral Care with Povidone-Iodine in the Prevention of Ventilator-Associated Pneumonia; a Systematic Review and Meta-Analysis.","authors":"Amir Emami Zeydi,&nbsp;Arman Parvizi,&nbsp;Soudabeh Haddadi,&nbsp;Samad Karkhah,&nbsp;Seyed Javad Hosseini,&nbsp;Amirabbas Mollaei,&nbsp;Mahbobeh Firooz,&nbsp;Shahin Ramezani,&nbsp;Joseph Osuji,&nbsp;Pooyan Ghorbani Vajargah,&nbsp;Shadi Dehghanzadeh","doi":"10.22037/aaem.v11i1.1874","DOIUrl":"https://doi.org/10.22037/aaem.v11i1.1874","url":null,"abstract":"<p><strong>Introduction: </strong>Ventilator-associated pneumonia (VAP) is one of the most common nosocomial infections affecting one-third of patients with mechanical ventilation. This study aimed to synthesize available evidence regarding the effect of treatment with povidone-iodine (PI) among adult patients admitted to intensive care units (ICUs) for the prevention of VAP.</p><p><strong>Methods: </strong>An extensive search was conducted in online databases, including PubMed, Web of Science and Scopus, from the earliest records until January 1, 2023. STATA software v14 was used for statistical analysis. Publication bias was assessed via funnel plot, Begg's and Egger's tests. A P-value less than 0.1 was considered statistically significant for publication bias value.</p><p><strong>Results: </strong>Four studies were included in the meta-analysis. Three studies showed rhat PI decreased VAP compared to the placebo group, but it was not statistically significant (RR: 0.61, 95%CI: 0.25 to 1.47, Z=1.10, P=0.27, I2:71.5%). One study compared the effect of PI with chlorhexidine on the rate of VAP, the difference between which was not statistically significant (RR: 1.50, 95%CI: 0.46 to 4.87, Z=0.67, P=0.50, I2:0). Two studies demonstrated that the use of PI intervention compared to placebo decreased the average length of stay in ICU; however, it was not statistically significant (WMD: -0.35, 95%CI:-3.90 to 3.20, Z=0.19, P=0.85, I2:0). Also, three studies showed that using PI had almost no effect on mortality rate compared to placebo (RR: 1.05, 95%CI: 0.66 to 1.53, Z=0.8, P=0.27, I2:29.0%).</p><p><strong>Conclusion: </strong>More rigorously designed randomized clinical trials and further evidence are required to make a better decision/comparison about using PI as a suitable choice for preventing VAP among adult patients admitted to the ICU.</p>","PeriodicalId":8146,"journal":{"name":"Archives of Academic Emergency Medicine","volume":"11 1","pages":"e31"},"PeriodicalIF":5.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0c/1b/aaem-11-e31.PMC10197909.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9506102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Value of CRASH and IMPACT Models for Predicting Mortality and Unfavorable Outcome in Traumatic Brain Injury; a Systematic Review and Meta-Analysis. CRASH和IMPACT模型预测颅脑外伤死亡率和不良结局的预后价值系统评价和荟萃分析。
IF 5.4 Q1 EMERGENCY MEDICINE Pub Date : 2023-01-01 DOI: 10.22037/aaem.v11i1.1885
Hamed Zarei, Mohammadhossein Vazirizadeh-Mahabadi, Hamzah Adel Ramawad, Arash Sarveazad, Mahmoud Yousefifard

Introduction: The Corticosteroid Randomization After Significant Head injury (CRASH) and the International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) are two prognostic models frequently used in predicting the outcome of patients with traumatic brain injury. There are ongoing debates about which of the two models has a better prognostic value. This study aims to compare the CRASH and IMPACT in predicting mortality and unfavorable outcome of patients with traumatic brain injury.

Method: We performed a literature search using Medline (via PubMed), Embase, Scopus, and Web of Science databases until August 17, 2022. After two independent researchers screened the articles, we included all the original articles comparing the prognostic value of IMPACT and CRASH models in patients with traumatic brain injury. The outcomes evaluated were mortality and unfavorable outcome. The data of the included articles were analyzed using STATA 17.0 statistical program, and we reported an odds ratio (OR) with a 95% confidence interval (95% CI) for comparison.

Results: We included the data from 16 studies. The analysis showed that the areas under the curve of the IMPACT core model and CRASH basic model do not differ in predicting the mortality of patients (OR=0.99; p=0.905) and their six-month unfavorable outcome (OR=1.01; p=0.719). Additionally, the CRASH CT model showed no difference from the IMPACT extended (OR=0.98; p=0.507) and IMPACT Lab (OR=1.00; p=0.298) models in predicting the mortality of patients with traumatic brain injury. We also observed similar findings in the six-month unfavorable outcome, showing that the CRASH CT model does not differ from the IMPACT extended (OR=1.00; p=0.990) and IMPACT Lab (OR=1.00; p=0.570) in predicting the unfavorable outcome in head trauma patients.

Conclusion: Low to very low level of evidence shows that IMPACT and CRASH models have similar values in predicting mortality and unfavorable outcome in patients with traumatic brain injury. Since the discriminative power of the IMPACT Core and CRASH basic models is not different from the IMPACT extended, IMPACT Lab, and CRASH CT models, it may be possible to only use the core and basic models in examining the prognosis of patients with traumatic injuries to the brain.

重大脑损伤后皮质类固醇随机化(CRASH)和国际临床试验预后与分析任务(IMPACT)是两种常用的预测外伤性脑损伤患者预后的预后模型。关于这两种模型中哪一种具有更好的预测价值的争论正在进行中。本研究旨在比较CRASH和IMPACT在预测外伤性脑损伤患者死亡率和不良预后方面的作用。方法:截至2022年8月17日,我们使用Medline(通过PubMed)、Embase、Scopus和Web of Science数据库进行文献检索。在两位独立研究人员筛选文章后,我们纳入了所有比较IMPACT和CRASH模型对创伤性脑损伤患者预后价值的原始文章。评估的结果是死亡率和不良结果。采用STATA 17.0统计程序对纳入文献的资料进行分析,采用95%可信区间(95% CI)的优势比(OR)进行比较。结果:我们纳入了16项研究的数据。分析表明,IMPACT核心模型和CRASH基本模型的曲线下面积在预测患者死亡率方面没有差异(OR=0.99;p=0.905)和6个月的不良结局(OR=1.01;p = 0.719)。此外,CRASH CT模型与IMPACT扩展模型没有差异(OR=0.98;p=0.507)和IMPACT Lab (OR=1.00;P =0.298)模型在预测颅脑损伤患者死亡率中的应用价值。我们在六个月的不利结果中也观察到类似的结果,表明CRASH CT模型与IMPACT扩展模型没有差异(OR=1.00;p=0.990)和IMPACT Lab (OR=1.00;P =0.570)预测颅脑外伤患者不良预后。结论:低至极低水平的证据表明,IMPACT和CRASH模型在预测外伤性脑损伤患者的死亡率和不良预后方面具有相似的价值。由于IMPACT Core和CRASH基本模型与IMPACT extended、IMPACT Lab和CRASH CT模型的判别能力并无差异,因此在检查颅脑创伤患者的预后时,可能只使用Core和基本模型。
{"title":"Prognostic Value of CRASH and IMPACT Models for Predicting Mortality and Unfavorable Outcome in Traumatic Brain Injury; a Systematic Review and Meta-Analysis.","authors":"Hamed Zarei,&nbsp;Mohammadhossein Vazirizadeh-Mahabadi,&nbsp;Hamzah Adel Ramawad,&nbsp;Arash Sarveazad,&nbsp;Mahmoud Yousefifard","doi":"10.22037/aaem.v11i1.1885","DOIUrl":"https://doi.org/10.22037/aaem.v11i1.1885","url":null,"abstract":"<p><strong>Introduction: </strong>The Corticosteroid Randomization After Significant Head injury (CRASH) and the International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) are two prognostic models frequently used in predicting the outcome of patients with traumatic brain injury. There are ongoing debates about which of the two models has a better prognostic value. This study aims to compare the CRASH and IMPACT in predicting mortality and unfavorable outcome of patients with traumatic brain injury.</p><p><strong>Method: </strong>We performed a literature search using Medline (via PubMed), Embase, Scopus, and Web of Science databases until August 17, 2022. After two independent researchers screened the articles, we included all the original articles comparing the prognostic value of IMPACT and CRASH models in patients with traumatic brain injury. The outcomes evaluated were mortality and unfavorable outcome. The data of the included articles were analyzed using STATA 17.0 statistical program, and we reported an odds ratio (OR) with a 95% confidence interval (95% CI) for comparison.</p><p><strong>Results: </strong>We included the data from 16 studies. The analysis showed that the areas under the curve of the IMPACT core model and CRASH basic model do not differ in predicting the mortality of patients (OR=0.99; p=0.905) and their six-month unfavorable outcome (OR=1.01; p=0.719). Additionally, the CRASH CT model showed no difference from the IMPACT extended (OR=0.98; p=0.507) and IMPACT Lab (OR=1.00; p=0.298) models in predicting the mortality of patients with traumatic brain injury. We also observed similar findings in the six-month unfavorable outcome, showing that the CRASH CT model does not differ from the IMPACT extended (OR=1.00; p=0.990) and IMPACT Lab (OR=1.00; p=0.570) in predicting the unfavorable outcome in head trauma patients.</p><p><strong>Conclusion: </strong>Low to very low level of evidence shows that IMPACT and CRASH models have similar values in predicting mortality and unfavorable outcome in patients with traumatic brain injury. Since the discriminative power of the IMPACT Core and CRASH basic models is not different from the IMPACT extended, IMPACT Lab, and CRASH CT models, it may be possible to only use the core and basic models in examining the prognosis of patients with traumatic injuries to the brain.</p>","PeriodicalId":8146,"journal":{"name":"Archives of Academic Emergency Medicine","volume":"11 1","pages":"e27"},"PeriodicalIF":5.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/66/bf/aaem-11-e27.PMC10008242.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9128879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Out-Of-Hour Admission on Fluid Treatment of Emergency Department Patients with Suspected Infection; a Multicenter Post-Hoc Analysis. 非分时入院对急诊疑似感染患者输液治疗的影响多中心事后分析。
IF 5.4 Q1 EMERGENCY MEDICINE Pub Date : 2023-01-01 DOI: 10.22037/aaem.v11i1.1839
Marie Kristine Jessen, Anna Drescher Petersen, Hans Kirkegaard

Introduction: Sepsis is a life-threatening and common cause of Emergency department (ED) referrals. Out-of-hour staffing is limited in ED, which may potentially affect fluid administration. This study aimed to investigate fluid volume variation in out-of-hour vs. routine-hour admissions.

Methods: The present study is a post-hoc analysis of a multicentre, prospective, observational study investigating fluid administration in ED patients with suspected infection, from Jan 20th - March 2nd, 2020. Patient groups were "routine-hours" (RH): weekdays 07:00-18:59 or "out-of-hours" (OOH): weekdays 19:00-06:59 or Friday 19:00-Monday 06:59. Primary outcome was 24-hour total fluid volumes (oral + intravenous (IV)). Secondary outcomes were total fluids 0-6 hours, oral fluids 0-6 and 0-24 hours, and IV fluids 0-6 and 0-24 hours. Linear regression adjusted for site and illness severity was used.

Results: 734 patients had suspected infection; 449 were admitted during RH and 287 during OOH. Mean (95% CI) total 24-hour fluid volumes were equal in simple infection and sepsis regardless of admission time: Simple infection RH: 3640 (3410 - 3871) ml and OOH: 3681 (3451 - 3913) ml. Sepsis RH: 3671 (3443;3898) ml and OOH: 3896 (3542;4250) ml. Oral fluids 0-6h were reduced in simple infection and sepsis among OOH vs. RH. Sepsis patients received more 0-6-hour IV fluid when admitted OOH vs. RH. There were no associations between admission time and 0-24-hour oral or IV volumes in simple infection or sepsis.

Conclusion: Admission time did not have an association with 24-hour total fluid volumes. Sepsis patients admitted during OOH received more 0-6-hour IV fluids than RH patients, and simple infection and sepsis patients received less oral fluid in 0-6 hours if admitted during OOH vs. RH.

简介:败血症是危及生命的常见原因急诊科(ED)转诊。急诊室的非工作时间人员有限,这可能会影响液体管理。本研究旨在调查非工作时间与正常工作时间入院患者的体液量变化。方法:本研究是对一项多中心、前瞻性、观察性研究的事后分析,该研究调查了2020年1月20日至3月2日期间ED疑似感染患者的液体给药。患者分组为“常规时间”(RH):工作日07:00-18:59或“非工作时间”(OOH):工作日19:00-06:59或周五19:00-周一06:59。主要终点是24小时总液体量(口服+静脉注射)。次要结果为总液体0-6小时,口服液体0-6和0-24小时,静脉液体0-6和0-24小时。采用校正部位和疾病严重程度的线性回归。结果:734例疑似感染;RH期间入院449人,OOH期间入院287人。无论入院时间如何,单纯感染和脓毒症患者24小时总液体体积的平均值(95% CI)相同:单纯感染RH: 3640 (3410 - 3871) ml, OOH: 3681 (3451 - 3913) ml。脓毒症患者RH: 3671 (3443;3898) ml, OOH: 3896 (3542;4250) ml。单纯感染和脓毒症患者0-6h的口服液减少。脓毒症患者接受0-6小时静脉输液时,OOH比RH更多。单纯感染或败血症患者入院时间与0-24小时口服或静脉注射量无相关性。结论:入院时间与24小时总液体容量无关。在户外活动期间入院的败血症患者比RH患者在0-6小时内接受更多的静脉输液,单纯感染和败血症患者在0-6小时内接受的口服液少于RH患者。
{"title":"Effect of Out-Of-Hour Admission on Fluid Treatment of Emergency Department Patients with Suspected Infection; a Multicenter Post-Hoc Analysis.","authors":"Marie Kristine Jessen,&nbsp;Anna Drescher Petersen,&nbsp;Hans Kirkegaard","doi":"10.22037/aaem.v11i1.1839","DOIUrl":"https://doi.org/10.22037/aaem.v11i1.1839","url":null,"abstract":"<p><strong>Introduction: </strong>Sepsis is a life-threatening and common cause of Emergency department (ED) referrals. Out-of-hour staffing is limited in ED, which may potentially affect fluid administration. This study aimed to investigate fluid volume variation in out-of-hour vs. routine-hour admissions.</p><p><strong>Methods: </strong>The present study is a post-hoc analysis of a multicentre, prospective, observational study investigating fluid administration in ED patients with suspected infection, from Jan 20<sup>th</sup> - March 2<sup>nd,</sup> 2020. Patient groups were \"routine-hours\" (RH): weekdays 07:00-18:59 or \"out-of-hours\" (OOH): weekdays 19:00-06:59 or Friday 19:00-Monday 06:59. Primary outcome was 24-hour total fluid volumes (oral + intravenous (IV)). Secondary outcomes were total fluids 0-6 hours, oral fluids 0-6 and 0-24 hours, and IV fluids 0-6 and 0-24 hours. Linear regression adjusted for site and illness severity was used.</p><p><strong>Results: </strong>734 patients had suspected infection; 449 were admitted during RH and 287 during OOH. Mean (95% CI) total 24-hour fluid volumes were equal in simple infection and sepsis regardless of admission time: Simple infection RH: 3640 (3410 - 3871) ml and OOH: 3681 (3451 - 3913) ml. Sepsis RH: 3671 (3443;3898) ml and OOH: 3896 (3542;4250) ml. Oral fluids 0-6h were reduced in simple infection and sepsis among OOH vs. RH. Sepsis patients received more 0-6-hour IV fluid when admitted OOH vs. RH. There were no associations between admission time and 0-24-hour oral or IV volumes in simple infection or sepsis.</p><p><strong>Conclusion: </strong>Admission time did not have an association with 24-hour total fluid volumes. Sepsis patients admitted during OOH received more 0-6-hour IV fluids than RH patients, and simple infection and sepsis patients received less oral fluid in 0-6 hours if admitted during OOH vs. RH.</p>","PeriodicalId":8146,"journal":{"name":"Archives of Academic Emergency Medicine","volume":"11 1","pages":"e21"},"PeriodicalIF":5.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/12/e3/aaem-11-e21.PMC10008217.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9617183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of L-Citrulline Supplementation on Outcomes of Critically Ill Patients under Mechanical Ventilation; a Double-Blind Randomized Controlled Trial. 补充l -瓜氨酸对危重患者机械通气预后的影响一项双盲随机对照试验。
IF 5.4 Q1 EMERGENCY MEDICINE Pub Date : 2023-01-01 DOI: 10.22037/aaem.v11i1.1774
Mohammad Reza Asgary, Sayid Mahdi Mirghazanfari, Ebrahim Hazrati, Vahid Hadi, Mojgan Mehri Ardestani, Faeze Bani Yaghoobi, Saeid Hadi
<p><strong>Introduction: </strong>Effective parenteral and enteral amino acid replacement is crucial for critically ill patients with altered amino acid metabolism. This study aimed to assess the effects of l-citrulline supplementation on the clinical and laboratory outcomes in critically patients.</p><p><strong>Methods: </strong>This was a double-blind placebo-controlled randomized clinical trial. 82 critically ill patients who were expected to receive mechanical ventilation for more than 72 hours were selected. The patients were assigned to either a placebo or an intervention group. The patients in the placebo group received 10 gr of microcrystalline cellulose and the ones in the intervention group were given l-citrulline daily for 7 days. Serum levels of fasting blood sugar (FBS), lipid profile, hepatic enzymes, serum electrolytes, urea nitrogen, creatinine, and C-reactive protein (CRP) were evaluated before and after the intervention. Duration of invasive ventilation, intensive care unit (ICU) length of stay, ventilator-free days, and 28-day mortality rate were recorded and compared between groups.</p><p><strong>Results: </strong>Eighty-two patients completed the trial. No statistically significant differences were observed between the two groups in terms of age (p = 0.46), sex (p = 0.49), body mass index (BMI) (p = 0.41), Sequential Organ Failure Assessment (SOFA) Score (p = 0.08), Clinical Pulmonary Infection Score (CPIS) score (p = 0.76), Acute Physiology and Chronic Health Evaluation (APACHE II) score (p = 0.58), risk factors (p = 0.13), ICU stay before randomization (p = 0.32), and reason of admission (p = 0.50) before the intervention. Citrulline group had a notable reduction in FBS (p = 0.04), total cholesterol (TC) (p = 0.02), low density lipoprotein (LDL-C) (p <0.001) and high-sensitivity CRP (hs-CRP) (p <0.001). Also, a significant increase in lactate dehydrogenase (LDH) concentration (p <0.001) was observed in the intervention group at the end of the trial. Total duration of invasive ventilation and the mean SOFA score on 7th day were significantly lower in the citrulline group compared to the control group. Moreover, a significant increase in days alive and ventilator-free days within 28 days after admission was found in the citrulline group at the end of the trial. Also, there were no significant differences between the groups in terms of mortality rate during intervention, serious adverse events, endotracheal intubation, the use of tracheotomy or non-invasive ventilation after extubation, length of ICU stay, ICU-free days at 28 days, and CPIS and APACHE II scores. For mortality, in the citrulline group, there was two deaths compared to eight deaths in the control group. This resulted in an absolute risk reduction (ARR) of 14.05% (95% CI: 0.39-27.71%) and a number needed to treat (NNT) of 7.1 (95% CI: 3.6-29.5), regarding mortality.</p><p><strong>Conclusions: </strong>The results of the present study demonstrated the probable pos
有效的肠外和肠内氨基酸替代对于氨基酸代谢改变的危重患者至关重要。本研究旨在评估补充l-瓜氨酸对危重患者临床和实验室结果的影响。方法:采用双盲、安慰剂对照的随机临床试验。选择机械通气时间超过72小时的危重患者82例。这些患者被分为安慰剂组和干预组。安慰剂组患者给予10克微晶纤维素,干预组患者给予l-瓜氨酸,每天7天。评估干预前后空腹血糖(FBS)、血脂、肝酶、血清电解质、尿素氮、肌酐和c反应蛋白(CRP)的血清水平。记录两组患者有创通气时间、重症监护病房(ICU)住院时间、无呼吸机天数和28天死亡率并进行比较。结果:82例患者完成了试验。两组患者干预前年龄(p = 0.46)、性别(p = 0.49)、体重指数(BMI) (p = 0.41)、序期器官衰竭评估(SOFA)评分(p = 0.08)、临床肺部感染评分(CPIS)评分(p = 0.76)、急性生理与慢性健康评估(APACHE II)评分(p = 0.58)、危险因素(p = 0.13)、随机分组前ICU住院时间(p = 0.32)、入院原因(p = 0.50)差异均无统计学意义。瓜氨酸组FBS (p = 0.04)、总胆固醇(TC) (p = 0.02)、低密度脂蛋白(LDL-C) (p)显著降低。结论:本研究结果表明,补充瓜氨酸对血脂、hs-CRP水平、有创通气持续时间和SOFA评分可能有积极影响。此外,l-瓜氨酸的消耗可能会增加没有机械通气的生存概率。
{"title":"The Effect of L-Citrulline Supplementation on Outcomes of Critically Ill Patients under Mechanical Ventilation; a Double-Blind Randomized Controlled Trial.","authors":"Mohammad Reza Asgary,&nbsp;Sayid Mahdi Mirghazanfari,&nbsp;Ebrahim Hazrati,&nbsp;Vahid Hadi,&nbsp;Mojgan Mehri Ardestani,&nbsp;Faeze Bani Yaghoobi,&nbsp;Saeid Hadi","doi":"10.22037/aaem.v11i1.1774","DOIUrl":"https://doi.org/10.22037/aaem.v11i1.1774","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Effective parenteral and enteral amino acid replacement is crucial for critically ill patients with altered amino acid metabolism. This study aimed to assess the effects of l-citrulline supplementation on the clinical and laboratory outcomes in critically patients.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This was a double-blind placebo-controlled randomized clinical trial. 82 critically ill patients who were expected to receive mechanical ventilation for more than 72 hours were selected. The patients were assigned to either a placebo or an intervention group. The patients in the placebo group received 10 gr of microcrystalline cellulose and the ones in the intervention group were given l-citrulline daily for 7 days. Serum levels of fasting blood sugar (FBS), lipid profile, hepatic enzymes, serum electrolytes, urea nitrogen, creatinine, and C-reactive protein (CRP) were evaluated before and after the intervention. Duration of invasive ventilation, intensive care unit (ICU) length of stay, ventilator-free days, and 28-day mortality rate were recorded and compared between groups.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Eighty-two patients completed the trial. No statistically significant differences were observed between the two groups in terms of age (p = 0.46), sex (p = 0.49), body mass index (BMI) (p = 0.41), Sequential Organ Failure Assessment (SOFA) Score (p = 0.08), Clinical Pulmonary Infection Score (CPIS) score (p = 0.76), Acute Physiology and Chronic Health Evaluation (APACHE II) score (p = 0.58), risk factors (p = 0.13), ICU stay before randomization (p = 0.32), and reason of admission (p = 0.50) before the intervention. Citrulline group had a notable reduction in FBS (p = 0.04), total cholesterol (TC) (p = 0.02), low density lipoprotein (LDL-C) (p &lt;0.001) and high-sensitivity CRP (hs-CRP) (p &lt;0.001). Also, a significant increase in lactate dehydrogenase (LDH) concentration (p &lt;0.001) was observed in the intervention group at the end of the trial. Total duration of invasive ventilation and the mean SOFA score on 7th day were significantly lower in the citrulline group compared to the control group. Moreover, a significant increase in days alive and ventilator-free days within 28 days after admission was found in the citrulline group at the end of the trial. Also, there were no significant differences between the groups in terms of mortality rate during intervention, serious adverse events, endotracheal intubation, the use of tracheotomy or non-invasive ventilation after extubation, length of ICU stay, ICU-free days at 28 days, and CPIS and APACHE II scores. For mortality, in the citrulline group, there was two deaths compared to eight deaths in the control group. This resulted in an absolute risk reduction (ARR) of 14.05% (95% CI: 0.39-27.71%) and a number needed to treat (NNT) of 7.1 (95% CI: 3.6-29.5), regarding mortality.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The results of the present study demonstrated the probable pos","PeriodicalId":8146,"journal":{"name":"Archives of Academic Emergency Medicine","volume":"11 1","pages":"e11"},"PeriodicalIF":5.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/65/c3/aaem-11-e11.PMC9807954.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10500462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Point-Of-Care Ultrasonography for Identification of Skin and Soft Tissue Abscess in Adult and Pediatric Patients; a Systematic Review and Meta-Analysis. 成人及儿童皮肤软组织脓肿的即时超声诊断系统评价和荟萃分析。
IF 5.4 Q1 EMERGENCY MEDICINE Pub Date : 2023-01-01 DOI: 10.22037/aaem.v11i1.2021
Erfan Rahmani, Ehsan Fayyazishishavan, Arian Afzalian, Sanaz Varshochi, Reza Amani-Beni, Seyed-Amirabbas Ahadiat, Zeynab Moshtaghi, Seyyed-Ghavam Shafagh, Roya Khorram, Elnaz Asadollahzade, Raihaneh Atbaei, Mohammad Saeed Kahrizi, Atoosa Rahbari, Negar Baharlouie, Farzaneh Mostanbet, Bahamin Amirabadiquchani, Moein Kiani, Mozhdeh Memarizadeh, Shahin Keshtkar Rajabi, Reza Barati, Hengame Hajinouri, Shahrzad Najafi, Zeynab Abdollahi, Nahid Dadashzadehasl, Atousa Moghadam Fard, Mozhgan Afshar, Atefeh Abedi, Sara Saeidi, Adeleh Mansourirad, Pedram Emami Shahrezaei, Sepideh Shah Hosseini, Zahra Rostami Ghotbabadi, Reza Vafadar, Roozbeh Roohinezhad, Nogol Ghalamkarpour, Mehrdad Farrokhi

Introduction: Differentiating the soft tissue abscess from other types of skin and soft tissue infections (SSTIs) poses a particular challenge because they have similar physical evaluation findings, but each disease has a different course, outcome, and treatment. This meta-analysis aimed to investigate the diagnostic accuracy of point-of-care ultrasonography for diagnosis of soft tissue abscess in the emergency departments.

Methods: A comprehensive literature search of MEDLINE, Scopus, Web of Science, Embase, and Google Scholar, from inception to January 2023, was conducted to identify relevant studies investigating the diagnostic performance of point-of-care ultrasonography for identification of abscess. Methodological quality of the included studies was assessed using a revised tool for the quality assessment of diagnostic accuracy studies (QUADAS-2).

Results: The pooled estimates of diagnostic parameters of ultrasonography for diagnosis of abscess were as follows: sensitivity, 0.93 (95% CI: 0.92-0.94); specificity, 0.87 (95% CI: 0.85-0.89), and the area under the summary receiver-operating characteristic (SROC), 0.95. The pooled sensitivity, specificity, and area under the SROC of studies in adult patients were 0.98 (95% CI: 0.92-1), 0.92 (95% CI: 0.86-0.95), and 0.99, respectively. The pooled sensitivity, specificity, and area under the SROC of studies in pediatric patients were 0.9 (95% CI: 0.87-0.92), 0.78 (95% CI: 0.73-0.82), and 0.91, respectively.

Conclusion: Our meta-analysis demonstrated that the point-of-care ultrasonography has excellent diagnostic value for the abscess in the emergency department. Furthermore, we found that the diagnostic performance of point-of-care ultrasonography for diagnosis of abscess was higher for adult cases than for pediatric patients.

将软组织脓肿与其他类型的皮肤和软组织感染(SSTIs)区分开来是一个特别的挑战,因为它们具有相似的物理评估结果,但每种疾病都有不同的过程、结果和治疗方法。本荟萃分析旨在探讨急诊现场超声诊断软组织脓肿的准确性。方法:综合检索MEDLINE、Scopus、Web of Science、Embase、Google Scholar等数据库自成立至2023年1月的相关文献,寻找即时超声诊断脓肿的相关研究。使用修订后的诊断准确性研究质量评估工具(QUADAS-2)评估纳入研究的方法学质量。结果:超声诊断脓肿的诊断参数汇总估计如下:敏感性为0.93 (95% CI: 0.92 ~ 0.94);特异性为0.87 (95% CI: 0.85-0.89),综合受者操作特征(SROC)下面积为0.95。在成人患者中,合并的敏感性、特异性和SROC下的面积分别为0.98 (95% CI: 0.92-1)、0.92 (95% CI: 0.86-0.95)和0.99。在儿科患者的研究中,合并的敏感性、特异性和SROC下的面积分别为0.9 (95% CI: 0.87-0.92)、0.78 (95% CI: 0.73-0.82)和0.91。结论:我们的荟萃分析表明,即时超声检查对急诊科的脓肿有很好的诊断价值。此外,我们发现,点护理超声诊断脓肿的诊断性能,成人病例高于儿童患者。
{"title":"Point-Of-Care Ultrasonography for Identification of Skin and Soft Tissue Abscess in Adult and Pediatric Patients; a Systematic Review and Meta-Analysis.","authors":"Erfan Rahmani,&nbsp;Ehsan Fayyazishishavan,&nbsp;Arian Afzalian,&nbsp;Sanaz Varshochi,&nbsp;Reza Amani-Beni,&nbsp;Seyed-Amirabbas Ahadiat,&nbsp;Zeynab Moshtaghi,&nbsp;Seyyed-Ghavam Shafagh,&nbsp;Roya Khorram,&nbsp;Elnaz Asadollahzade,&nbsp;Raihaneh Atbaei,&nbsp;Mohammad Saeed Kahrizi,&nbsp;Atoosa Rahbari,&nbsp;Negar Baharlouie,&nbsp;Farzaneh Mostanbet,&nbsp;Bahamin Amirabadiquchani,&nbsp;Moein Kiani,&nbsp;Mozhdeh Memarizadeh,&nbsp;Shahin Keshtkar Rajabi,&nbsp;Reza Barati,&nbsp;Hengame Hajinouri,&nbsp;Shahrzad Najafi,&nbsp;Zeynab Abdollahi,&nbsp;Nahid Dadashzadehasl,&nbsp;Atousa Moghadam Fard,&nbsp;Mozhgan Afshar,&nbsp;Atefeh Abedi,&nbsp;Sara Saeidi,&nbsp;Adeleh Mansourirad,&nbsp;Pedram Emami Shahrezaei,&nbsp;Sepideh Shah Hosseini,&nbsp;Zahra Rostami Ghotbabadi,&nbsp;Reza Vafadar,&nbsp;Roozbeh Roohinezhad,&nbsp;Nogol Ghalamkarpour,&nbsp;Mehrdad Farrokhi","doi":"10.22037/aaem.v11i1.2021","DOIUrl":"https://doi.org/10.22037/aaem.v11i1.2021","url":null,"abstract":"<p><strong>Introduction: </strong>Differentiating the soft tissue abscess from other types of skin and soft tissue infections (SSTIs) poses a particular challenge because they have similar physical evaluation findings, but each disease has a different course, outcome, and treatment. This meta-analysis aimed to investigate the diagnostic accuracy of point-of-care ultrasonography for diagnosis of soft tissue abscess in the emergency departments.</p><p><strong>Methods: </strong>A comprehensive literature search of MEDLINE, Scopus, Web of Science, Embase, and Google Scholar, from inception to January 2023, was conducted to identify relevant studies investigating the diagnostic performance of point-of-care ultrasonography for identification of abscess. Methodological quality of the included studies was assessed using a revised tool for the quality assessment of diagnostic accuracy studies (QUADAS-2).</p><p><strong>Results: </strong>The pooled estimates of diagnostic parameters of ultrasonography for diagnosis of abscess were as follows: sensitivity, 0.93 (95% CI: 0.92-0.94); specificity, 0.87 (95% CI: 0.85-0.89), and the area under the summary receiver-operating characteristic (SROC), 0.95. The pooled sensitivity, specificity, and area under the SROC of studies in adult patients were 0.98 (95% CI: 0.92-1), 0.92 (95% CI: 0.86-0.95), and 0.99, respectively. The pooled sensitivity, specificity, and area under the SROC of studies in pediatric patients were 0.9 (95% CI: 0.87-0.92), 0.78 (95% CI: 0.73-0.82), and 0.91, respectively.</p><p><strong>Conclusion: </strong>Our meta-analysis demonstrated that the point-of-care ultrasonography has excellent diagnostic value for the abscess in the emergency department. Furthermore, we found that the diagnostic performance of point-of-care ultrasonography for diagnosis of abscess was higher for adult cases than for pediatric patients.</p>","PeriodicalId":8146,"journal":{"name":"Archives of Academic Emergency Medicine","volume":"11 1","pages":"e49"},"PeriodicalIF":5.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c4/10/aaem-11-e49.PMC10440756.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10055732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HEART versus GRACE Score in Predicting the Outcomes of Patients with Acute Coronary Syndrome; a Systematic Review and Meta-Analysis. HEART与GRACE评分预测急性冠脉综合征患者预后的比较系统评价和荟萃分析。
IF 5.4 Q1 EMERGENCY MEDICINE Pub Date : 2023-01-01 DOI: 10.22037/aaem.v11i1.2001
Ali Kabiri, Pantea Gharin, Seyed Ali Forouzannia, Koohyar Ahmadzadeh, Reza Miri, Mahmoud Yousefifard

Introduction: Several scoring systems have been proposed to predict the outcomes of patients with ischemic heart disease. Global Registry of Acute Coronary Events (GRACE) and History, ECG, Age, Risk Factors, and Troponin (HEART) scores are two of the more widely used risk prediction tools in patients with acute coronary syndrome (ACS). The present systematic review and meta-analysis aimed to compare the value of GRACE and HEART scores in the outcome prediction of ACS patient.

Method: The online databases of Medline, Embase, Web of Science, and Scopus were search until September 2022 for articles directly comparing GRACE and HEART scores value in prediction of outcome in patients with ACS. GRACE score cut-offs were categorized into two groups of less than and equal to 100 and more than 100, and HEART score cut-offs were categorized into three groups of less than 4, equal to 4, and more than 4. Investigated outcomes were major adverse cardiovascular events (MACE), acute myocardial infraction (AMI) and all-cause mortality.

Results: 25 articles were included. The sensitivity and specificity of the GRACE score for prediction of MACE were 0.96 and 0.26 for cut-offs of ≤ 100, and 0.58 and 0.69 for cut-offs of >100, respectively. The sensitivity and specificity of the HEART score for prediction of MACE were 0.99 and 0.16 for cut-offs less than 4, 0.93 and 0.47 for equal to 4, and 0.77 and 0.78 for cut-offs greater than 4. GRACE score was shown to be predictive of AMI with sensitivity and specificity of 0.95 and 0.29, respectively. The analysis for the value of HEART score in the prediction of AMI a sensitivity and specificity of 0.94 and 0.48, respectively. The risk scores were not found to be suitable predictors of all-cause mortality.

Conclusion: The results demonstrated the low specificity of GRACE and HEART scores in predicting the MACE, AMI and all-cause mortality, irrespective of the utilized cut-off. Considering the acceptable sensitivity of two scores in predicting the MACE and AMI, these scores were more suitable to be used as a rule-out tool for identification of ACS patients with low risk of developing adverse outcomes.

已经提出了几种评分系统来预测缺血性心脏病患者的预后。全球急性冠状动脉事件登记(GRACE)和病史、心电图、年龄、危险因素和肌钙蛋白(HEART)评分是急性冠状动脉综合征(ACS)患者中两种更广泛使用的风险预测工具。本系统综述和荟萃分析旨在比较GRACE和HEART评分在ACS患者预后预测中的价值。方法:检索Medline、Embase、Web of Science和Scopus等在线数据库,检索到2022年9月前直接比较GRACE和HEART评分对ACS患者预后预测价值的文章。GRACE评分截止点分为小于等于100分和大于100分两组,HEART评分截止点分为小于4分、等于4分和大于4分三组。研究结果为主要不良心血管事件(MACE)、急性心肌梗死(AMI)和全因死亡率。结果:共纳入25篇文章。GRACE评分预测MACE的敏感度和特异度在临界值≤100时分别为0.96和0.26,在临界值>100时分别为0.58和0.69。cut off小于4时,HEART评分预测MACE的敏感性和特异性分别为0.99和0.16;cut off等于4时,敏感性和特异性分别为0.93和0.47;cut off大于4时,敏感性和特异性分别为0.77和0.78。GRACE评分预测AMI的敏感性和特异性分别为0.95和0.29。HEART评分预测AMI的敏感性和特异性分别为0.94和0.48。风险评分不适合作为全因死亡率的预测指标。结论:结果显示GRACE和HEART评分在预测MACE、AMI和全因死亡率方面的特异性较低,与使用的截止值无关。考虑到两种评分在预测MACE和AMI方面的可接受敏感性,这两种评分更适合作为一种排除工具,用于识别发生不良结局风险较低的ACS患者。
{"title":"HEART versus GRACE Score in Predicting the Outcomes of Patients with Acute Coronary Syndrome; a Systematic Review and Meta-Analysis.","authors":"Ali Kabiri,&nbsp;Pantea Gharin,&nbsp;Seyed Ali Forouzannia,&nbsp;Koohyar Ahmadzadeh,&nbsp;Reza Miri,&nbsp;Mahmoud Yousefifard","doi":"10.22037/aaem.v11i1.2001","DOIUrl":"https://doi.org/10.22037/aaem.v11i1.2001","url":null,"abstract":"<p><strong>Introduction: </strong>Several scoring systems have been proposed to predict the outcomes of patients with ischemic heart disease. Global Registry of Acute Coronary Events (GRACE) and History, ECG, Age, Risk Factors, and Troponin (HEART) scores are two of the more widely used risk prediction tools in patients with acute coronary syndrome (ACS). The present systematic review and meta-analysis aimed to compare the value of GRACE and HEART scores in the outcome prediction of ACS patient.</p><p><strong>Method: </strong>The online databases of Medline, Embase, Web of Science, and Scopus were search until September 2022 for articles directly comparing GRACE and HEART scores value in prediction of outcome in patients with ACS. GRACE score cut-offs were categorized into two groups of less than and equal to 100 and more than 100, and HEART score cut-offs were categorized into three groups of less than 4, equal to 4, and more than 4. Investigated outcomes were major adverse cardiovascular events (MACE), acute myocardial infraction (AMI) and all-cause mortality.</p><p><strong>Results: </strong>25 articles were included. The sensitivity and specificity of the GRACE score for prediction of MACE were 0.96 and 0.26 for cut-offs of ≤ 100, and 0.58 and 0.69 for cut-offs of >100, respectively. The sensitivity and specificity of the HEART score for prediction of MACE were 0.99 and 0.16 for cut-offs less than 4, 0.93 and 0.47 for equal to 4, and 0.77 and 0.78 for cut-offs greater than 4. GRACE score was shown to be predictive of AMI with sensitivity and specificity of 0.95 and 0.29, respectively. The analysis for the value of HEART score in the prediction of AMI a sensitivity and specificity of 0.94 and 0.48, respectively. The risk scores were not found to be suitable predictors of all-cause mortality.</p><p><strong>Conclusion: </strong>The results demonstrated the low specificity of GRACE and HEART scores in predicting the MACE, AMI and all-cause mortality, irrespective of the utilized cut-off. Considering the acceptable sensitivity of two scores in predicting the MACE and AMI, these scores were more suitable to be used as a rule-out tool for identification of ACS patients with low risk of developing adverse outcomes.</p>","PeriodicalId":8146,"journal":{"name":"Archives of Academic Emergency Medicine","volume":"11 1","pages":"e50"},"PeriodicalIF":5.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/13/7b/aaem-11-e50.PMC10440758.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10061426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing the Emergency Medicine Residency Programs in Iran and around the World; a Descriptive Study. 伊朗与世界各国急诊医学住院医师制度比较描述性研究。
IF 5.4 Q1 EMERGENCY MEDICINE Pub Date : 2023-01-01 DOI: 10.22037/aaem.v11i1.1867
Mahdi Talebi, Morteza Talebi Doluee, Mohamadali Jafari, Hamid Zamani Moghaddam, Mahdi Foroughian, Mojtaba Moazzami, Hassan Gholami, Hamidreza Reihani

Introduction: To identify the strengths and weaknesses of emergency medicine residency curriculum in Iran, and to benefit from the experiences of successful universities, comparative studies are crucial. This study compared the components of the national curriculum of emergency medicine in the United States, Canada, the European Union, Australia, and Saudi Arabia with Iran.

Method: Data for this research was collected by searching the websites of different universities and also contacting them for requesting curriculums. The leading countries in emergency medicine and one of the countries in the Middle East region (Saudi Arabia) along with the World Federation of Emergency Medicine were selected as the sample. The model used in this field is a range model that identifies four stages of description, interpretation, proximity, and comparison in comparative studies.

Results: In the curriculum of the United States, Canada, the European Union, Australia, and Saudi Arabia, there were lots of similarities in expressing the general characteristics of the curriculum, mission elements, vision, values, and ​beliefs of the discipline, educational strategy, techniques, expected competencies, rotation programs, and evaluation method, which were also similar to the Iranian curriculum. However, the duration of residency for emergency medicine in Iran is three years, which is shorter than other countries. As expected, the number and duration of rotations are less than other countries. Also, the process of entering into this field is different in Iran and is based on an exam for entrance, while most other countries use self-requested residency program.

Conclusion: Considering the results of comparing the Iranian curriculum with the curriculums of the United States, Canada, the European Union, Australia, and Saudi Arabia, it seems that Iran's program is comprehensive and complete; but, a reappraisal of the course duration and entering options are necessary to eliminate or improve the inadequacies.

导言:为了确定伊朗急诊医学住院医师课程的优势和劣势,并从成功大学的经验中获益,比较研究至关重要。本研究比较了美国、加拿大、欧盟、澳大利亚和沙特阿拉伯与伊朗急诊医学国家课程的组成部分。方法:本研究的资料收集方式为搜寻各大学的网站,并联络各大学索取课程资料。选取急诊医学的领先国家和中东地区的一个国家(沙特阿拉伯)以及世界急诊医学联合会作为样本。在这个领域中使用的模型是一个范围模型,它确定了比较研究中的描述、解释、接近和比较四个阶段。结果:美国、加拿大、欧盟、澳大利亚和沙特阿拉伯的课程在表达课程的总体特征、使命要素、学科愿景、价值观和信念、教育策略、技术、期望能力、轮岗计划和评价方法等方面与伊朗课程有很多相似之处。然而,伊朗急诊医师的居留期限为三年,比其他国家短。正如预期的那样,轮调的次数和时间比其他国家少。此外,进入这个领域的过程在伊朗是不同的,是基于入学考试,而大多数其他国家使用自我要求的居留计划。结论:从伊朗课程与美国、加拿大、欧盟、澳大利亚和沙特阿拉伯的课程比较结果来看,伊朗的课程似乎是全面和完整的;但是,重新评估课程的持续时间和进入选项是必要的,以消除或改善不足。
{"title":"Comparing the Emergency Medicine Residency Programs in Iran and around the World; a Descriptive Study.","authors":"Mahdi Talebi,&nbsp;Morteza Talebi Doluee,&nbsp;Mohamadali Jafari,&nbsp;Hamid Zamani Moghaddam,&nbsp;Mahdi Foroughian,&nbsp;Mojtaba Moazzami,&nbsp;Hassan Gholami,&nbsp;Hamidreza Reihani","doi":"10.22037/aaem.v11i1.1867","DOIUrl":"https://doi.org/10.22037/aaem.v11i1.1867","url":null,"abstract":"<p><strong>Introduction: </strong>To identify the strengths and weaknesses of emergency medicine residency curriculum in Iran, and to benefit from the experiences of successful universities, comparative studies are crucial. This study compared the components of the national curriculum of emergency medicine in the United States, Canada, the European Union, Australia, and Saudi Arabia with Iran.</p><p><strong>Method: </strong>Data for this research was collected by searching the websites of different universities and also contacting them for requesting curriculums. The leading countries in emergency medicine and one of the countries in the Middle East region (Saudi Arabia) along with the World Federation of Emergency Medicine were selected as the sample. The model used in this field is a range model that identifies four stages of description, interpretation, proximity, and comparison in comparative studies.</p><p><strong>Results: </strong>In the curriculum of the United States, Canada, the European Union, Australia, and Saudi Arabia, there were lots of similarities in expressing the general characteristics of the curriculum, mission elements, vision, values, and ​beliefs of the discipline, educational strategy, techniques, expected competencies, rotation programs, and evaluation method, which were also similar to the Iranian curriculum. However, the duration of residency for emergency medicine in Iran is three years, which is shorter than other countries. As expected, the number and duration of rotations are less than other countries. Also, the process of entering into this field is different in Iran and is based on an exam for entrance, while most other countries use self-requested residency program.</p><p><strong>Conclusion: </strong>Considering the results of comparing the Iranian curriculum with the curriculums of the United States, Canada, the European Union, Australia, and Saudi Arabia, it seems that Iran's program is comprehensive and complete; but, a reappraisal of the course duration and entering options are necessary to eliminate or improve the inadequacies.</p>","PeriodicalId":8146,"journal":{"name":"Archives of Academic Emergency Medicine","volume":"11 1","pages":"e13"},"PeriodicalIF":5.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1f/05/aaem-11-e13.PMC9807940.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10507413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Periosteal Nerve Block Vs. Intravenous Morphine in Pain Relief of Distal Radius and Ulna Fracture; a Double-Blind Randomized Clinical Trial. 骨膜神经阻滞与静脉吗啡对桡骨、尺骨远端骨折疼痛的缓解作用一项双盲随机临床试验
IF 5.4 Q1 EMERGENCY MEDICINE Pub Date : 2023-01-01 DOI: 10.22037/aaem.v11i1.2056
Shadi Ashtari, Alireza Hasanzadeh, Alireza Bahmani, Ali Abdolrazaghnejad

Introduction: Distal forearm fractures' realignment and fixation is a painful procedure. This study aimed to compare the efficacy of periosteal nerve block and intravenous morphine in distal radius and ulna fractures' pain management.

Methods: In the present randomized, parallel, double-blind, controlled clinical trial, patients with distal radius or ulna fractures were divided into two groups. In the first group, for periosteal nerve block, 1% lidocaine was injected at a distance of 6 to 8 cm near the wrist from the lateral radius and medial ulna. In the second group, morphine sulfate at a dose of 0.1 mg/kg was slowly injected through the peripheral vein within 5 minutes. The visual analog scale (VAS) score was evaluated before the intervention and every 15 minutes until 90 minutes after the intervention and was compared between the two groups.

Results: 75 subjects were studied (39 in the periosteal nerve block and 36 in the intravenous morphine group). There were no significant differences between the groups in terms of mean age (p = 0.384), gender distribution (p = 0.464), past medical history (p = 0.106), trauma type (p = 0.836), fracture type (p = 0.613), and baseline pain severity on VAS (p = 0.987). Both methods reduced the VAS scores during the 90 minutes of the study. The mean pain scores of the patients in the periosteal nerve block group with 2.56±1.44, 2.15±1.11, 2.66±1.26, and 3±1.27 at 15, 30, 45, and 60 minutes after the analgesic injection, respectively, were significantly lower than those of the intravenous morphine group with 4.75±1.27, 4.22±1.22, 3.97±1.27, and 4.13±1.35, respectively (p < 0.001 for all comparisons). In the present study, no local or systemic complications were observed in the periosteal nerve block group, while the complications of dyspnea, vomiting, and pruritus were reported by 5.5%, 2.8%, and 2.8%, respectively, in the intravenous morphine group. Moreover, the percentage of need for additional analgesia in the intravenous morphine group was higher than that of the periosteal nerve block group.

Conclusion: In the first hour after the intervention, pain reduction in periosteal block was significantly higher than intravenous morphine administration. Also, the incidence of complications and the need for additional analgesia were lower in the periosteal block group compared to intravenous morphine administration.

简介:前臂远端骨折的复位和固定是一个痛苦的过程。本研究旨在比较骨膜神经阻滞和静脉注射吗啡治疗桡骨远端骨折和尺骨远端骨折疼痛的疗效。方法:采用随机、平行、双盲、对照临床试验,将桡骨或尺骨远端骨折患者分为两组。第一组骨膜神经阻滞,1%利多卡因在距桡骨外侧、尺骨内侧近腕6 ~ 8 cm处注射。第二组在5分钟内通过外周静脉缓慢注射剂量为0.1 mg/kg的硫酸吗啡。在干预前及干预后每15分钟至90分钟评估一次视觉模拟量表(VAS)评分,比较两组间的差异。结果:共75例受试者(骨膜神经阻滞组39例,静脉注射吗啡组36例)。在平均年龄(p = 0.384)、性别分布(p = 0.464)、既往病史(p = 0.106)、创伤类型(p = 0.836)、骨折类型(p = 0.613)和VAS基线疼痛严重程度(p = 0.987)方面,组间差异无统计学意义。在90分钟的研究中,两种方法都降低了VAS评分。骨膜神经阻滞组患者在镇痛药注射后15、30、45、60分钟的平均疼痛评分分别为2.56±1.44、2.15±1.11、2.66±1.26、3±1.27,显著低于静脉注射吗啡组的4.75±1.27、4.22±1.22、3.97±1.27、4.13±1.35,差异均有统计学意义(p < 0.001)。本研究中,骨膜神经阻滞组未出现局部或全身并发症,而静脉注射吗啡组出现呼吸困难、呕吐和瘙痒的发生率分别为5.5%、2.8%和2.8%。此外,静脉注射吗啡组需要额外镇痛的百分比高于骨膜神经阻滞组。结论:干预后1小时,骨膜阻滞镇痛效果明显高于静脉注射吗啡。此外,与静脉注射吗啡相比,骨膜阻滞组的并发症发生率和额外镇痛的需要更低。
{"title":"Periosteal Nerve Block Vs. Intravenous Morphine in Pain Relief of Distal Radius and Ulna Fracture; a Double-Blind Randomized Clinical Trial.","authors":"Shadi Ashtari,&nbsp;Alireza Hasanzadeh,&nbsp;Alireza Bahmani,&nbsp;Ali Abdolrazaghnejad","doi":"10.22037/aaem.v11i1.2056","DOIUrl":"https://doi.org/10.22037/aaem.v11i1.2056","url":null,"abstract":"<p><strong>Introduction: </strong>Distal forearm fractures' realignment and fixation is a painful procedure. This study aimed to compare the efficacy of periosteal nerve block and intravenous morphine in distal radius and ulna fractures' pain management.</p><p><strong>Methods: </strong>In the present randomized, parallel, double-blind, controlled clinical trial, patients with distal radius or ulna fractures were divided into two groups. In the first group, for periosteal nerve block, 1% lidocaine was injected at a distance of 6 to 8 cm near the wrist from the lateral radius and medial ulna. In the second group, morphine sulfate at a dose of 0.1 mg/kg was slowly injected through the peripheral vein within 5 minutes. The visual analog scale (VAS) score was evaluated before the intervention and every 15 minutes until 90 minutes after the intervention and was compared between the two groups.</p><p><strong>Results: </strong>75 subjects were studied (39 in the periosteal nerve block and 36 in the intravenous morphine group). There were no significant differences between the groups in terms of mean age (p = 0.384), gender distribution (p = 0.464), past medical history (p = 0.106), trauma type (p = 0.836), fracture type (p = 0.613), and baseline pain severity on VAS (p = 0.987). Both methods reduced the VAS scores during the 90 minutes of the study. The mean pain scores of the patients in the periosteal nerve block group with 2.56±1.44, 2.15±1.11, 2.66±1.26, and 3±1.27 at 15, 30, 45, and 60 minutes after the analgesic injection, respectively, were significantly lower than those of the intravenous morphine group with 4.75±1.27, 4.22±1.22, 3.97±1.27, and 4.13±1.35, respectively (p < 0.001 for all comparisons). In the present study, no local or systemic complications were observed in the periosteal nerve block group, while the complications of dyspnea, vomiting, and pruritus were reported by 5.5%, 2.8%, and 2.8%, respectively, in the intravenous morphine group. Moreover, the percentage of need for additional analgesia in the intravenous morphine group was higher than that of the periosteal nerve block group.</p><p><strong>Conclusion: </strong>In the first hour after the intervention, pain reduction in periosteal block was significantly higher than intravenous morphine administration. Also, the incidence of complications and the need for additional analgesia were lower in the periosteal block group compared to intravenous morphine administration.</p>","PeriodicalId":8146,"journal":{"name":"Archives of Academic Emergency Medicine","volume":"11 1","pages":"e51"},"PeriodicalIF":5.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/96/a1/aaem-11-e51.PMC10475742.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10170198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archives of Academic Emergency Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1